Viewing Study NCT06732960


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-01-04 @ 1:21 AM
Study NCT ID: NCT06732960
Status: COMPLETED
Last Update Posted: 2025-04-02
First Post: 2024-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients
Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module